Table 2. Hi3 peptide quantitative analysis of abundant plasma proteins.
No | Protein name | median (ng/mL) | IRV | IAV | AV | LIN | ST | LOQ | n | FN |
1 | Albumin | 7.4 x107 | 12 | 15 | 11 | 0.992 | 0.955 | 6.0 x103 | 31 | 1 |
2 | Ig gamma | 4.8 x106 | 30 | 17 | 5 | 0.985 | 0.998 | 8.5 x104 | 31 | 2 |
3 | Serotransferrin | 2.7 x106 | 19 | 19 | 9 | 0.991 | 0.976 | 2.6 x105 | 31 | 3 |
4 | Fibrinogen | 2.6 x106 | 14 | 15 | 9 | 0.995 | 0.991 | 7.0 x104 | 30 | 4 |
5 | Complement C3 | 2.3 x106 | 17 | 16 | 7 | 0.987 | 0.974 | 5.6 x104 | 31 | 5 |
6 | Alpha-2-macroglobulin | 1.8 x106 | 16 | 11 | 4 | 0.990 | 0.993 | 5.2 x104 | 31 | 6 |
7 | Apolipoprotein A-I | 1.7 x106 | 29 | 14 | 8 | 0.991 | 0.976 | 2.2 x104 | 31 | 7 |
8 | Alpha-1-antitrypsin | 1.6 x106 | 14 | 16 | 15 | 0.985 | 0.964 | 2.7 x104 | 31 | 8 |
9 | Haptoglobin | 1.3 x106 | 26 | 20 | 9 | 0.993 | 0.991 | 3.2 x104 | 31 | 9 |
10 | Ig kappa chain C region | 1.0 x106 | 25 | 14 | 8 | 0.989 | 0.985 | 1.7 x104 | 31 | 10 |
11 | Apolipoprotein B-100 | 9.7 x105 | 14 | 15 | 9 | 0.966 | 0.999 | 2.5 x105 | 31 | 11 |
12 | Hemopexin | 9.1 x105 | 12 | 12 | 4 | 0.999 | 0.960 | 2.1 x104 | 31 | 12 |
13 | Ig alpha | 7.3 x105 | 18 | 17 | 8 | 0.998 | 0.982 | 2.3 x104 | 31 | 13 |
14 | Complement C4 | 6.8 x105 | 16 | 16 | 14 | 0.979 | - | 1.3 x105 | 31 | 14 |
15 | Fibronectin | 5.0 x105 | - | - | 32 | - | - | - | 22 | 15 |
16 | Ig lambda chain C region | 4.0 x105 | 22 | 17 | 7 | 0.989 | 0.976 | 1.5 x104 | 31 | 16 |
17 | Ceruloplasmin | 3.5 x105 | 22 | 16 | 8 | 0.990 | 0.992 | 1.8 x104 | 31 | 17 |
18 | Inter-alpha-trypsin inhibitor hc H2 | 3.5 x105 | 14 | 18 | 14 | 0.991 | 0.965 | 2.4 x104 | 31 | 18 |
19 | Complement factor H | 2.7 x105 | 20 | 20 | 5 | 0.991 | 0.990 | 3.3 x104 | 31 | 19 |
20 | Vitamin D-binding protein | 2.7 x105 | 15 | 15 | 9 | 0.994 | 0.993 | 3.3 x104 | 31 | 20 |
21 | Kininogen-1 | 2.6 x105 | 17 | 14 | 10 | 0.989 | 0.963 | 3.6 x104 | 31 | 21 |
22 | Alpha-2-HS-glycoprotein | 2.4 x105 | 16 | 13 | 12 | 0.990 | 0.961 | 4.0 x103 | 31 | 22 |
23 | Plasminogen | 2.2 x105 | 22 | 20 | 11 | 0.991 | 0.983 | 4.7 x104 | 31 | 23 |
24 | Ig mu chain C region | 2.2 x105 | 26 | 14 | 17 | 0.993 | 0.997 | 1.4 x104 | 31 | 24 |
25 | Apolipoprotein A-II | 2.0 x105 | 27 | 17 | 6 | 0.995 | 0.988 | 2.4 x104 | 31 | 25 |
26 | Alpha-1-antichymotrypsin | 1.8 x105 | 16 | 6 | 6 | 0.989 | 0.961 | 6.0 x103 | 31 | 26 |
27 | Inter-alpha-trypsin inhibitor hc H1 | 1.8 x105 | 16 | - | 18 | 0.993 | - | 4.4 x104 | 31 | 27 |
28 | Alpha-1-acid glycoprotein 1 | 1.7 x105 | 41 | 16 | 10 | 0.990 | 0.971 | 6.0 x103 | 31 | 28 |
29 | Beta-2-glycoprotein 1 | 1.7 x105 | 11 | 31 | 7 | 0.993 | 0.966 | 7.2 x104 | 31 | 29 |
30 | Inter-alpha-trypsin inhibitor hc H4 | 1.7 x105 | 43 | 10 | 7 | 0.993 | 0.995 | 2.0 x104 | 31 | 30 |
31 | Complement factor B | 1.5 x105 | 25 | 52 | 11 | 0.995 | 0.974 | 2.5 x104 | 31 | 31 |
32 | Clusterin | 1.5 x105 | 10 | 17 | 10 | 0.990 | 0.958 | 1.7 x104 | 31 | 32 |
33 | Alpha-1B-glycoprotein | 1.4 x105 | 18 | 12 | 9 | 0.989 | 0.955 | 1.0 x104 | 31 | 33 |
34 | Prothrombin | 1.4 x105 | 16 | 23 | 51 | 0.993 | 0.974 | 1.7 x104 | 31 | 34 |
35 | Antithrombin-III | 1.4 x105 | 20 | 19 | 7 | 0.984 | 0.962 | 5.0 x103 | 31 | 35 |
36 | Plasma protease C1 inhibitor | 1.3 x105 | 19 | 18 | 10 | 0.964 | 0.966 | 1.1 x104 | 31 | 36 |
37 | Vitronectin | 1.1 x105 | 13 | 13 | 10 | 0.995 | 0.982 | 1.4 x104 | 28 | 37 |
38 | Apolipoprotein A-IV | 1.0 x105 | 18 | 16 | 9 | 0.994 | 0.972 | 9.0 x103 | 31 | 38 |
39 | C4b-binding protein alpha chain | 1.0 x105 | 18 | 13 | 35 | 0.996 | 0.997 | 1.5 x104 | 31 | 39 |
40 | Histidine-rich glycoprotein | 9.0 x104 | 21 | 13 | 10 | 0.976 | 0.958 | 8.0 x103 | 31 | 40 |
No | Protein name | median (ng/mL) | IRV | IAV | AV | LIN | ST | LOQ | n | FN |
41 | Gelsolin | 7.0 x104 | 23 | 36 | 11 | 0.990 | - | 3.5 x104 | 22 | 41 |
42 | Heparin cofactor 2 | 6.6 x104 | 17 | - | 100 | 0.991 | - | 1.1 x104 | 11 | 42 |
43 | Afamin | 5.7 x104 | 16 | 12 | 15 | 0.998 | 0.954 | 1.0 x105 | 18 | 43 |
44 | Angiotensinogen | 5.7 x104 | 19 | 16 | 5 | 0.989 | 0.992 | 1.1 x104 | 30 | 44 |
45 | Paraoxonase/arylesterase 1 | 5.1 x104 | 22 | - | 22 | 0.982 | 0.999 | 7.0 x103 | 23 | 45 |
46 | Alpha-1-acid glycoprotein 2 | 5.0 x104 | 44 | 15 | 13 | 0.999 | 0.958 | 4.0 x103 | 31 | 46 |
47 | Hemoglobin subunit alpha | 4.1 x104 | 40 | - | 7 | 0.991 | - | 3.0 x103 | 31 | 47 |
48 | Apolipoprotein C-III | 3.9 x104 | 32 | 27 | 20 | - | 0.978 | 1.4 x104 | 31 | 48 |
49 | Protein AMBP | 3.9 x104 | 26 | 10 | 16 | 0.825 | 0.949 | 7.0 x103 | 22 | 49 |
50 | Hemoglobin subunit beta | 3.8 x104 | 17 | 42 | 8 | 0.992 | 0.983 | 4.0 x103 | 31 | 50 |
51 | Pregnancy zone protein | 3.6 x104 | 64 | 64 | 75 | 0.959 | 0.998 | 7.0 x103 | 15 | - |
52 | Zinc alpha 2 glycoprotein | 3.3 x104 | 24 | 12 | 212 | 0.772 | 0.971 | 4.0 x103 | 20 | 51 |
53 | Apolipoprotein E | 3.1 x104 | 19 | 6 | 11 | 0.996 | 0.964 | 1.7 x104 | 27 | 52 |
54 | CD5 antigen like protein | 2.5 x104 | 8 | 7 | 15 | - | 0.997 | 1.3 x104 | 19 | - |
55 | Haptoglobin-related protein | 2.3 x104 | 24 | 24 | 21 | 0.968 | 0.995 | 3.0 x103 | 16 | 53 |
56 | Retinol-binding protein 4 | 2.2 x104 | 20 | - | 27 | - | - | - | 14 | 54 |
57 | Apolipoprotein D | 2.1 x104 | - | - | 13 | - | - | - | 20 | 55 |
58 | Apolipoprotein C-I | 1.6 x104 | - | - | 11 | - | - | - | 26 | 56 |
59 | Apolipoprotein C-II | 1.6 x104 | - | 23 | 7 | - | 0.922 | - | 19 | 57 |
Median (ng/mL): median of protein concentrations determined from number of samples shown in column n. IRV: inter-assay variation, the coefficients of variation obtained from 7 aliquots of a pooled sample separately digested and measured over the course of 3 months of normal operation of the instrument. IAV: intra-assay variation, coefficient of variation obtained from 6 aliquots of a pooled sample separately digested and subsequently measured during 1 day. AV: analytical variability, determined from 10 replicate injections of a single digested sample throughout 9 days of measurements. LIN: linearity of measurements, the Pearson’s correlation coefficient shows linearity between total protein load on the analytical column and nanogram protein quantified by HI3 peptide quantitation using the ADH1 digest standard; only determined when at least 4 points were available for a protein. See also S1 Fig. ST: Pearson’s correlation of protein quantitation using two different digest standards (ADH1 and ENO1 from yeast). LOQ: limit of quantitation (ng/mL) estimated by dilution of a plasma sample in a constant background of a digest standard. n: number of samples (out of 31) in which the protein was quantified, FN: protein number on the x-axis of Fig 1c. hc: heavy chain.